Results of studies investigating therapeutic drugs and targets for the induction of KCs with fatty acid in models of NAFLD and NASH in the past 5 years abbreviations: IQ, Isoquercetin. This evidence concerns the gene TBCE and metabolic dysfunction-associated steatohepatitis.